Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q2 FY2013 Earnings Presentation
21 slides from Apollo Hospitals Enterprise's earnings presentation, November 2012
Slide 1: Q2 FY 2013 Earnings Update
Q2 FY 2013 Earnings Update Q2 FY 2013 Earnings Update 1
Slide 2: Safe Harbour
Safe Harbour No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the
Slide 3: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 3
Slide 4: Highlights – (1/2)
Highlights – (1/2) H1FY13 Consolidated Revenues of Rs. 18,433 mio (up 22.2% yoy) Financial Performance H1FY13 Consolidated EBITDA of Rs. 3,100 mio (up 25.0% yoy) H1FY13 Consolidated EBITDA margin at 16.8% as compared to 16.4% in H1FY12 Consolidated PAT of Rs. 1,625 mio (up 48.3% yoy) Chenn
Slide 5: Highlights – (2/2)
Highlights – (2/2) 49 hospitals with total bed capacity of 7,987 beds as on Sept 30, 2012 36 owned hospitals including JVs/ Subsidiaries and associates with 5,949 beds and Capacity 13 Managed hospitals with 2,038 beds. Of the 5,949 owned beds, 5,265 beds were operational and had an occupancy o
Slide 6: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 6
Slide 7: Consolidated Financial Performance
Consolidated Financial Performance (Unaudited Management Estimates) ` Mio Q2 FY 12 Q2 FY 13 yoy (%) H1 FY 12 H1 FY 13 yoy (%) Income from Operations 7,364 9,018 22.5% 14,151 17,274 22.1% Add: Share of JVs 484 602 24.5% 931 1,159 24.5% Total Revenues 7,847 9,621 22.6% 15,081 18,433 22.2% EBITDA 1,286
Slide 8: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 8
Slide 9: Standalone Financial Performance – (1/2)
Standalone Financial Performance – (1/2) ` Mio Q2 FY 12 Q2 FY 13 yoy (%) H1 FY 12 H1 FY 13 yoy (%) Key Highlights Revenue 6,998 8,363 19.5% 13,408 16,137 20.4% Operative Expenses 3,616 4,352 20.4% 6,998 8,350 19.3% Revenues of Rs. 16,137 mio, Employee Expenses 1,095 1,305 19.2% 2,057 2,562 24.6% 2
Slide 10: Standalone Segment-wise Performance – (2/2)
Standalone Segment-wise Performance – (2/2) ` Mio Q2 FY 12 Q2 FY 13 yoy (%) H1 FY 12 H1 FY 13 yoy (%) Key Highlights Revenues from each segment Healthcare services Revenues at Heathcare Services * 4,915 5,589 13.7% 9,429 10,888 15.5% Rs. 10,888 mio, 15.5% yoy Stand-alone Pharmacy 2,085 2,776 33.2%
Slide 11: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 11
Slide 12: Operational Performance – Hospitals
Operational Performance – Hospitals ` Mio Total (5) Chennai cluster Hyderabad cluster Others (1) Significant subs/ JVs/ associates (2) Particulars H1 FY 12 H1 FY 13 Growth H1 FY 12 H1 FY 13 Growth H1 FY 12 H1 FY 13 Growth H1 FY 12 H1 FY 13 Growth H1 FY 12 H1 FY 13 Growth yoy (%) yoy (%) yoy (%) yoy
Slide 13: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 13
Slide 14: Operational Performance – Standalone Pharmacy
Operational Performance – Standalone Pharmacy ` Mio Batch Particulars Q2 FY 12 Q2 FY 13 yoy % H1 FY 12 H1 FY 13 yoy % Key Highlights No of Stores 486 463 486 463 Upto FY Revenue/store 2.18 2.60 19.6% 4.27 5.02 17.5% 2008 EBITDA /store 0.10 0.14 34.2% 0.18 0.26 42.2% Batch All stores upto FY 2010 E
Slide 15: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 15
Slide 16: Key Hospital Expansion Plan & Update on Execution
Key Hospital Expansion Plan & Update on Execution Total Estim ated AHEL's Strategy for Expansion Project Share of Focus on owned hospitals Type of Cost Cost – Plan to add 15 hospitals from the current 36 Location CoD* Hospital No of Beds (Rs.m io) (Rs.m io) Mumbai Cluster – Plan to add 3,140 beds
Slide 17: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Standalone Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 17
Slide 18: Update on non-hospital JVs, Associates
Update on non-hospital JVs, Associates (Unaudited Management Estimates) ` Mio Particulars Q2 FY 12 Q2 FY 13 yoy (%) H1 FY 12 H1 FY 13 yoy (%) Y-O-Y revenue growth of 9%. Expansion in EBITDA margins by 243 bps Total Income 1,220 1,323 8% 2,441 2,667 9% at 17.8% in H1FY13 as compared to 15.4% in H
Slide 19: Q&A
Q&A 19
Slide 20: Appendix: Basis of Consolidation
Appendix: Basis of Consolidation AHEL Standalone Location Description Chennai Main Chennai Hospital ASH - Chennai Chennai Hospital Tondiarpet - Chennai Chennai Hospital FirstMed - Chennai Chennai Hospital Apollo Children's Hospital Chennai Hospital Madurai Madurai Hospital Karur Karur Hospital Karai
Slide 21: Hospitals – Understanding Key Operating Metrics
Hospitals – Understanding Key Operating Metrics Description Formula / Calculation Key Driver Number of operating - Project execution Operating Beds beds Capital Expenditure x In-patient Bed Days In-patient Bed Days Brand Occupancy Billed Doctor reputation Quality of outcomes Comp
Apollo Hospitals Enterprise — Q2 FY2013 Earnings Presentation on 6ix